Rejuve is developing an effective treatment for COPD (chronic obstructive pulmonary disease), the 3rd leading cause of death in the world. The solution Rejuve has developed slows down, stops, and even reverses the disease by 80% on average. The first company to reverse COPD and eliminate side effects will take significant market share. Rejuve Therapeutics will be the first to do this, based on their efficacy and safety data.
